D5DR Activators
Items 1 to 10 of 14 total
Display:
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
SKF 38393 hydrochloride | 62717-42-4 | sc-203264 | 25 mg | $50.00 | ||
SKF 38393 hydrochloride is a selective D5 dopamine receptor agonist, exhibiting a distinct affinity for the receptor that influences downstream signaling cascades. Its unique structural features allow for specific hydrogen bonding and hydrophobic interactions, enhancing receptor activation. The compound's dynamic conformational flexibility facilitates rapid binding kinetics, while its solubility characteristics influence its distribution in various environments, affecting its overall reactivity and interaction with biological membranes. | ||||||
Levodopa | 59-92-7 | sc-205372 sc-205372A | 5 g 25 g | $54.00 $171.00 | 9 | |
Precursor to dopamine, L-DOPA can increase dopamine levels, potentially enhancing D5DR activation. | ||||||
SKF 83959 | 67287-95-0 | sc-204285 sc-204285A | 10 mg 50 mg | $187.00 $786.00 | ||
SKF 83959 is a selective D5 dopamine receptor antagonist, characterized by its ability to modulate receptor activity through unique allosteric interactions. Its molecular structure promotes specific electrostatic and van der Waals forces, which stabilize receptor conformations. The compound exhibits notable kinetic properties, allowing for rapid dissociation from the receptor, thus influencing downstream signaling pathways. Additionally, its lipophilicity enhances membrane permeability, impacting its interaction dynamics within cellular environments. | ||||||
Dopamine-d4 Hydrochloride | 203633-19-6 | sc-218267 | 1 mg | $377.00 | 2 | |
Dopamine-d4 Hydrochloride acts as a selective D5 dopamine receptor modulator, distinguished by its capacity to engage in specific hydrogen bonding and hydrophobic interactions with receptor sites. This compound demonstrates unique reaction kinetics, facilitating a gradual onset of receptor activation. Its solubility characteristics enhance its diffusion across biological membranes, allowing for nuanced modulation of intracellular signaling cascades. The compound's structural features contribute to its distinct pharmacodynamic profile. | ||||||
SKF 83822 hydrobromide | 74115-10-9 | sc-204284 sc-204284A | 5 mg 50 mg | $198.00 $811.00 | ||
SKF 83822 hydrobromide is a selective D5 dopamine receptor modulator characterized by its unique ability to form stable ionic interactions with receptor binding sites. This compound exhibits distinct conformational flexibility, allowing it to adapt to various receptor states. Its kinetic profile reveals a slow dissociation rate, promoting sustained receptor engagement. Additionally, the compound's solubility in polar solvents enhances its distribution, influencing downstream signaling pathways effectively. | ||||||
Bromocriptine | 25614-03-3 | sc-337602A sc-337602B sc-337602 | 10 mg 100 mg 1 g | $57.00 $265.00 $567.00 | 4 | |
A dopamine agonist that can bind to dopamine receptors including D5DR, leading to its activation. | ||||||
(R)-(−)-Apomorphine hydrochloride | 314-19-2 | sc-203675A sc-203675 sc-203675B | 5 mg 50 mg 500 mg | $84.00 $161.00 $421.00 | ||
(R)-(-)-Apomorphine hydrochloride acts as a potent D5 dopamine receptor agonist, distinguished by its ability to induce conformational changes in receptor structure upon binding. This compound demonstrates a unique affinity for both D1 and D2 receptor subtypes, facilitating cross-talk between signaling pathways. Its stereochemistry contributes to specific interactions with the receptor's active site, enhancing its efficacy. The compound's hydrophilic nature allows for effective solvation, impacting its bioavailability and interaction dynamics. | ||||||
Ropinirole Hydrochloride | 91374-20-8 | sc-205843 sc-205843A | 25 mg 100 mg | $84.00 $317.00 | 1 | |
A selective dopamine D2/D3 receptor agonist, which may indirectly influence D5DR activity through dopaminergic signaling. | ||||||
(S)-Pramipexole Dihydrochloride | 104632-25-9 | sc-212895 | 10 mg | $164.00 | ||
Another D2/D3 agonist, pramipexole can elevate dopamine receptor activity, possibly affecting D5DR. | ||||||
1-Adamantylamine | 768-94-5 | sc-251475 sc-251475A | 1 g 25 g | $39.00 $147.00 | ||
Increases dopamine release and blocks its reuptake, potentially enhancing D5DR signaling. | ||||||